Growing incidence of blood related disorders is stimulating demand for apheresis equipment. In addition, growing awareness pertaining to donation of blood components such as plasma and platelets are likely to fuel the demand rate further. As per a report published by NHBST, demand for platelet is has grows at a rate of 3% per year, between 2011 and 2014. Moreover, demand rate of platelets is likely to enhance in coming years.
Growing Demand for Platelets in Various Blood Disorders Augment Adoption Rate of Apheresis Equipment
Platelets are required in case of blood disorders, which affect the clotting ability of an individual. Such blood disorders are sickle-cell diseases, hemophilia A, hemophilia B, and thalassemia. Rising prevalence of these blood disorders, despite the age factor, is likely to augment demand for apheresis devices.
Get Sample Copy of this Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1307
These devices could also help in the treatment process of rare disease, also termed as haemoglobinopathies. Wide application range of the device is likely to provide growth opportunities for apheresis devices market in healthcare sector.
Moreover, ongoing technological innovations in apheresis devices are resulting in the development of next-generation apheresis equipment. This, in turn, is anticipated to contribute to the global apheresis devices market, in terms of revenue.
Key Players Undergoes Collaborations For Development of Apheresis Market
Further, key companies operating in the global market is collaborating, and undertaking mergers and acquisition activities with aim of diversification of the product range of apheresis devices.
Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1307
For example, In April 2017, B. Braun entered into strategic alliance with Christie Medical Holdings Inc. The main aim behind the collaboration was to provide seamless devices for refining peripheral access to the healthcare professionals. Likewise, in January 2017, Hemacare Corporation announced collaboration with One Blood Inc. It is a Florida based blood center. The collaboration aided to the company growth and facilitated development of apheresis related products.